Revvity Inc
RVTY: XNYS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$991.00 | Xlmznv | Kfjkxtdk |
Narrow Moat PerkinElmer Reports Q4 Results; Shares Still Overvalued
Narrow-moat-rated PerkinElmer reported fourth-quarter results slightly topping previously reported guidance. We believe shares are overvalued, and there are no changes to our fair value estimate of $144 even after management raised its outlook for 2022, as strong demand for COVID-19 products are anticipated through the first quarter of 2022.